share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Officer Klima Thomas J

bluebird bio | 4:持股变动声明-高管 Klima Thomas J

SEC announcement ·  03/05 17:44
Moomoo AI 已提取核心信息
Thomas J Klima, associated with bluebird bio, Inc. [BLUE], completed a sale of 4,573 shares of common stock on March 4, 2024. The transaction was carried out in the open market at a price of $1.5276 per share, resulting in a total sale value of approximately $6,985.71. Following the sale, Klima's direct holdings in bluebird bio amount to 124,840 shares. The sale reflects a transaction status of completed.
Thomas J Klima, associated with bluebird bio, Inc. [BLUE], completed a sale of 4,573 shares of common stock on March 4, 2024. The transaction was carried out in the open market at a price of $1.5276 per share, resulting in a total sale value of approximately $6,985.71. Following the sale, Klima's direct holdings in bluebird bio amount to 124,840 shares. The sale reflects a transaction status of completed.
与蓝鸟生物有限公司 [BLUE] 相关的托马斯·克利马于2024年3月4日完成了4573股普通股的出售。该交易在公开市场上进行,价格为每股1.5276美元,总销售价值约为6,985.71美元。出售后,克利马直接持有的蓝鸟生物股份为124,840股。此次出售反映了交易状态为 “已完成”。
与蓝鸟生物有限公司 [BLUE] 相关的托马斯·克利马于2024年3月4日完成了4573股普通股的出售。该交易在公开市场上进行,价格为每股1.5276美元,总销售价值约为6,985.71美元。出售后,克利马直接持有的蓝鸟生物股份为124,840股。此次出售反映了交易状态为 “已完成”。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息